HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kevin J H Allen Selected Research

Synucleins

8/2022An HPLC-UV validated bioanalytical method for measurement of in vitro phase 1 kinetics of α-synuclein binding bifunctional compounds.
8/2021Employing in vitro metabolism to guide design of F-labelled PET probes of novel α-synuclein binding bifunctional compounds.
12/2016Novel Dimer Compounds That Bind α-Synuclein Can Rescue Cell Growth in a Yeast Model Overexpressing α-Synuclein. A Possible Prevention Strategy for Parkinson's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kevin J H Allen Research Topics

Disease

17Neoplasms (Cancer)
05/2024 - 11/2013
5Melanoma (Melanoma, Malignant)
07/2023 - 10/2018
4Osteosarcoma (Osteogenic Sarcoma)
05/2024 - 01/2019
3Parkinson Disease (Parkinson's Disease)
08/2022 - 12/2016
2Invasive Fungal Infections
01/2023 - 08/2020
2Infections
01/2023 - 01/2020
2Experimental Melanoma
11/2020 - 07/2019
2Virus Diseases (Viral Diseases)
08/2020 - 01/2020
1Disease Progression
04/2024
1Autoimmune Diseases (Autoimmune Disease)
04/2024
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
04/2024
1Inflammation (Inflammations)
04/2024
1Multiple Sclerosis
04/2024
1Obesity
01/2023
1Mucormycosis
01/2023
1COVID-19
01/2023
1Neurodegenerative Diseases (Neurodegenerative Disease)
08/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021
1Blastomycosis
01/2020
1Pancreatic Neoplasms (Pancreatic Cancer)
09/2019
1Testicular Neoplasms (Testicular Cancer)
09/2019
1Multiple Myeloma
01/2019
1Communicable Diseases (Infectious Diseases)
12/2018

Drug/Important Bio-Agent (IBA)

9Radioisotopes (Radionuclides)IBA
04/2024 - 10/2018
8AntibodiesIBA
05/2024 - 10/2018
7Melanins (Melanin)IBA
07/2023 - 10/2018
5Monoclonal AntibodiesIBA
10/2022 - 12/2018
3Lutetium-177IBA
05/2024 - 01/2023
3SynucleinsIBA
08/2022 - 12/2016
2AntigensIBA
01/2023 - 09/2019
2lintuzumabIBA
10/2022 - 01/2021
2Complement System Proteins (Complement)IBA
08/2022 - 01/2019
2Proteins (Proteins, Gene)FDA Link
08/2022 - 01/2021
2Caffeine (No Doz)FDA LinkGeneric
08/2022 - 08/2021
2Insulin (Novolin)FDA Link
05/2021 - 01/2019
2Indicators and Reagents (Reagents)IBA
07/2019 - 10/2018
2Immunoglobulin G (IgG)IBA
07/2019 - 10/2018
1Caspase 3 (Caspase-3)IBA
05/2024
1DNA (Deoxyribonucleic Acid)IBA
05/2024
1Actinium-225IBA
05/2024
1myelin oligodendrocyte glycoprotein (35-55)IBA
04/2024
1AutoantigensIBA
04/2024
1beta-1,3-glucanIBA
01/2023
1SteroidsIBA
01/2023
1Antifungal AgentsIBA
01/2023
11-aminoindanIBA
08/2022
1CarbonIBA
08/2022
1NicotineFDA Link
08/2022
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2021
1venetoclaxIBA
01/2021
1Immune Checkpoint InhibitorsIBA
11/2020
1Chimeric Antigen ReceptorsIBA
09/2020
1Bismuth-213IBA
08/2020
1beta-GlucansIBA
01/2020
1Therapeutic UsesIBA
01/2019
1Growth Factor ReceptorsIBA
01/2019
1daratumumabIBA
01/2019
1Chelating AgentsIBA
10/2018
1N-hydroxysuccinimide S-acetylthioacetate (SATA)IBA
10/2018
1Lysine (L-Lysine)FDA Link
11/2013
1Histones (Histone)IBA
11/2013

Therapy/Procedure

12Radioimmunotherapy
08/2023 - 10/2018
8Therapeutics
04/2024 - 08/2020
3Immunotherapy
08/2022 - 07/2019
2Precision Medicine
04/2024 - 07/2023
1Cell- and Tissue-Based Therapy (Cell Therapy)
09/2020